Immune Pharmaceuticals Inc.
IMNP
IMNP was delisted on the 25th of July, 2018.
15 hedge funds and large institutions have $768K invested in Immune Pharmaceuticals Inc. in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
36% more capital invested
Capital invested by funds: $565K → $768K (+$203K)
25% more funds holding
Funds holding: 12 → 15 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$311K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$157K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$67.9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$54.9K |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$36.5K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCM
1
Sio Capital Management
New York
| $233K | +$311K | +9,883 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $117K | +$157K | +4,996 | New |
|
|
PRCM
3
Pine River Capital Management
Minnetonka,
Minnesota
| $108K | – | – | – |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $78K | +$54.9K | +1,744 | +112% |
|
|
VKH
5
Virtu KCG Holdings
New York
| $51K | +$67.9K | +2,156 | New |
|
|
EEG
6
E.E. Geduld
| $41K | – | – | – |
|
7
Goldman Sachs
New York
| $35K | +$2.23K | +71 | +5% |
|
|
8
Nomura Holdings
Tokyo,
Japan
| $27K | +$36.5K | +1,160 | New |
|
|
IFS
9
Ifrah Financial Services
Little Rock,
Arkansas
| $26K | – | – | – |
|
|
TSS
10
Two Sigma Securities
New York
| $18K | +$24.4K | +774 | New |
|
|
BPCE
11
Bank Pictet & Cie (Europe)
Frankfurt Am Main,
Germany
| $15K | – | – | – |
|
12
UBS Group
Zurich,
Switzerland
| $9K | +$7.84K | +249 | +224% |
|
|
BIT
13
BlackRock Institutional Trust
San Francisco,
California
| $5K | – | – | – |
|
|
BIM
14
BlackRock Investment Management
Wilmington,
Delaware
| $4K | – | – | – |
|
|
LTFS
15
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
IMNP Hedge Fund Activity: Q3 2015 in Review
15 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Immune Pharmaceuticals Inc. (IMNP) for Q3 2015, worth a combined $768K — up 36% from $565K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new IMNP positions and 2 closed out — a net gain of 3 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Sio Capital Management, opening a new position worth an estimated $311K.
- 15 institutional investors held Immune Pharmaceuticals Inc. (IMNP) as of Q3 2015, up from 12 in Q2 2015.
- Funds reported $768K of Immune Pharmaceuticals Inc. stock for Q3 2015, up 36% quarter-over-quarter.
- 5 funds opened new Immune Pharmaceuticals Inc. positions in Q3 2015 and 2 closed out, a net change of +3 holders.
- The largest Immune Pharmaceuticals Inc. buyer in Q3 2015 was Sio Capital Management, an estimated $311K added.
Based on aggregated 13F filings for Q3 2015.